{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T13:03:53Z","timestamp":1779800633273,"version":"3.53.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Scientometrics"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s11192-026-05598-x","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:15:34Z","timestamp":1773850534000},"page":"1707-1730","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Awakening Sleeping Beauties from articles on mRNA vaccines against COVID-19"],"prefix":"10.1007","volume":"131","author":[{"given":"Artemis","family":"Chaleplioglou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathia","family":"Selinopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2948-1269","authenticated-orcid":false,"given":"Konstantinos","family":"Kyprianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Koulouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"issue":"2","key":"5598_CR1","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s11192-019-03233-5","volume":"121","author":"DW Aksnes","year":"2019","unstructured":"Aksnes, D. W., & Sivertsen, G. (2019). A criteria-based assessment of the coverage of Scopus and Web of Science. Scientometrics, 121(2), 983\u2013998. https:\/\/doi.org\/10.1007\/s11192-019-03233-5","journal-title":"Scientometrics"},{"issue":"10101","key":"5598_CR2","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/s0140-6736(17)31665-3","volume":"390","author":"M Alberer","year":"2017","unstructured":"Alberer, M., Gnad-Vogt, U., Hong, H. S., Mehr, K. T., Backert, L., Finak, G., Gottardo, R., Bica, M. A., Garofano, A., Koch, S. D., Fotin-Mleczek, M., Hoerr, I., Clemens, R., & Von Sonnenburg, F. (2017). Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: An open-label, non-randomised, prospective, first-in-human phase 1 clinical trial. The Lancet, 390(10101), 1511\u20131520. https:\/\/doi.org\/10.1016\/s0140-6736(17)31665-3","journal-title":"The Lancet"},{"issue":"5","key":"5598_CR4","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., & McGettigan, J. (2021). Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. New England Journal of Medicine, 384(5), 403\u2013416. https:\/\/doi.org\/10.1056\/NEJMoa2035389","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"5598_CR5","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.ymthe.2017.03.035","volume":"25","author":"K Bahl","year":"2017","unstructured":"Bahl, K., Senn, J. J., Yuzhakov, O., Bulychev, A., Brito, L. A., Hassett, K. J., Laska, M. E., Smith, M., Almarsson, \u00d6., Thompson, J., Ribeiro, A., Watson, M., Zaks, T., & Ciaramella, G. (2017). Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses. Molecular Therapy, 25(6), 1316\u20131327. https:\/\/doi.org\/10.1016\/j.ymthe.2017.03.035","journal-title":"Molecular Therapy"},{"issue":"9","key":"5598_CR6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1080\/14760584.2017.1357471","volume":"16","author":"PN Barrett","year":"2017","unstructured":"Barrett, P. N., Terpening, S. J., Snow, D., Cobb, R. R., & Kistner, O. (2017). Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases. Expert Review of Vaccines, 16(9), 883\u2013894. https:\/\/doi.org\/10.1080\/14760584.2017.1357471","journal-title":"Expert Review of Vaccines"},{"issue":"12","key":"5598_CR7","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1038\/mt.2014.133","volume":"22","author":"LA Brito","year":"2014","unstructured":"Brito, L. A., Chan, M., Shaw, C. A., Hekele, A., Carsillo, T., Schaefer, M., Archer, J., Seubert, A., Otten, G. R., Beard, C. W., Dey, A. K., Lilja, A., Valiante, N. M., Mason, P. W., Mandl, C. W., Barnett, S. W., Dormitzer, P. R., Ulmer, J. B., Singh, M., \u2026 Geall, A. J. (2014a). A cationic nanoemulsion for the delivery of next-generation RNA vaccines. Molecular Therapy, 22(12), 2118\u20132129. https:\/\/doi.org\/10.1038\/mt.2014.133","journal-title":"Molecular Therapy"},{"key":"5598_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/bs.adgen.2014.10.005","author":"LA Brito","year":"2014","unstructured":"Brito, L. A., Kommareddy, S., Maione, D., Uematsu, Y., Giovani, C., Scorza, F. B., Otten, G. R., Yu, D., Mandl, C. W., Mason, P. W., Dormitzer, P. R., Ulmer, J. B., & Geall, A. J. (2014b). Self-Amplifying mRNA vaccines. Advances in Genetics. https:\/\/doi.org\/10.1016\/bs.adgen.2014.10.005","journal-title":"Advances in Genetics"},{"key":"5598_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2016.38","volume":"5","author":"K Broos","year":"2016","unstructured":"Broos, K., Van Der Jeught, K., Puttemans, J., Goyvaerts, C., Heirman, C., Dewitte, H., Verbeke, R., Lentacker, I., Thielemans, K., & Breckpot, K. (2016). Particle-mediated intravenous delivery of antigen mRNA results in strong antigen-specific T-cell responses despite the induction of type I interferon. Molecular Therapy - Nucleic Acids, 5, Article e326. https:\/\/doi.org\/10.1038\/mtna.2016.38","journal-title":"Molecular Therapy - Nucleic Acids"},{"issue":"1","key":"5598_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/09610006211058908","volume":"55","author":"A Chaleplioglou","year":"2023","unstructured":"Chaleplioglou, A., & Koulouris, A. (2023). Preprint paper platforms in the academic scholarly communication environment. Journal of Librarianship and Information Science, 55(1), 43\u201356. https:\/\/doi.org\/10.1177\/09610006211058908","journal-title":"Journal of Librarianship and Information Science"},{"key":"5598_CR11","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","volume":"20","author":"N Chaudhary","year":"2021","unstructured":"Chaudhary, N., Weissman, D., & Whitehead, K. A. (2021). mRNA vaccines for infectious diseases: Principles, delivery and clinical translation. Nature Reviews. Drug Discovery, 20, 817\u2013838. https:\/\/doi.org\/10.1038\/s41573-021-00283-5","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"5","key":"5598_CR12","doi-asserted-by":"publisher","DOI":"10.2196\/26511","volume":"23","author":"C Chen","year":"2021","unstructured":"Chen, C., Song, M., Heo, G. E., & Park, H. (2021). A bibliometric analysis of COVID-19 research trends: A roadmap for future research. Journal of Medical Internet Research, 23(5), Article e26511. https:\/\/doi.org\/10.2196\/26511","journal-title":"Journal of Medical Internet Research"},{"issue":"2","key":"5598_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8020236","volume":"8","author":"VJ Clemente-Su\u00e1rez","year":"2020","unstructured":"Clemente-Su\u00e1rez, V. J., Horme\u00f1o-Holgado, A., Jim\u00e9nez, M., Benitez-Agudelo, J. C., Jim\u00e9nez, E. N., Palencia, N. P., Maestre-Serrano, R., Laborde-C\u00e1rdenas, C. C., & Tornero-Aguilera, J. F. (2020). Dynamics of population immunity due to the herd effect in the COVID-19 pandemic. Vaccines, 8(2), Article 236. https:\/\/doi.org\/10.3390\/vaccines8020236","journal-title":"Vaccines"},{"key":"5598_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.23750\/abm.v91i1.9397","volume":"91","author":"C Cucinotta","year":"2020","unstructured":"Cucinotta, C., & Vanelli, M. (2020). WHO declares COVID-19 a pandemic. Acta Bio-Medica: Atenei Parmensis, 91, 157\u2013160. https:\/\/doi.org\/10.23750\/abm.v91i1.9397","journal-title":"Acta Bio-Medica: Atenei Parmensis"},{"issue":"7","key":"5598_CR15","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s00705-020-04628-0","volume":"165","author":"V da Costa","year":"2020","unstructured":"da Costa, V., Moreli, M., & Saivish, M. (2020). The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century. Archives of Virology, 165(7), 1517\u20131526. https:\/\/doi.org\/10.1007\/s00705-020-04628-0","journal-title":"Archives of Virology"},{"key":"5598_CR16","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1056\/NEJMoa030747","volume":"348","author":"C Drosten","year":"2003","unstructured":"Drosten, C., Gunther, S., Preiser, W., van der Werf, S., Brodt, H. R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A., & Berger, A. (2003). Identification of a novel coronavirus in patients with severe acute respiratory syndrome. The New England Journal of Medicine, 348, 1967\u20131076. https:\/\/doi.org\/10.1056\/NEJMoa030747","journal-title":"The New England Journal of Medicine"},{"key":"5598_CR53","doi-asserted-by":"publisher","unstructured":"Fazeli-Varzaneh, M., Ghorbi, A., Ausloos, M., Sallinger, E., & Sahar Vahdati. (2021). Sleeping beauties of coronavirus research. IEEE Access, 9, 21192\u201321205. https:\/\/doi.org\/10.1109\/access.2021.3052918","DOI":"10.1109\/access.2021.3052918"},{"issue":"1","key":"5598_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/cji.0b013e3181f7dbe8","volume":"34","author":"M Fotin-Mleczek","year":"2010","unstructured":"Fotin-Mleczek, M., Duchardt, K. M., Lorenz, C., Pfeiffer, R., Ojki\u0107-Zrna, S., Probst, J., & Kallen, K. (2010). Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity. Journal of Immunotherapy, 34(1), 1\u201315. https:\/\/doi.org\/10.1097\/cji.0b013e3181f7dbe8","journal-title":"Journal of Immunotherapy"},{"issue":"3","key":"5598_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/gt.2017.5","volume":"24","author":"S Guan","year":"2017","unstructured":"Guan, S., & Rosenecker, J. (2017). Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems. Gene Therapy, 24(3), 133\u2013143. https:\/\/doi.org\/10.1038\/gt.2017.5","journal-title":"Gene Therapy"},{"key":"5598_CR55","doi-asserted-by":"publisher","unstructured":"Haghani, M., & Varamini, P. (2021). Temporal evolution, most infl uential studies and sleeping beauties of the coronavirus literature. Scientometrics, 126(8), 7005\u20137050. https:\/\/doi.org\/10.1007\/s11192-021-04036-4","DOI":"10.1007\/s11192-021-04036-4"},{"key":"5598_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/natrevmats.2017.56","author":"KA Hajj","year":"2017","unstructured":"Hajj, K. A., & Whitehead, K. A. (2017). Tools for translation: Non-viral materials for therapeutic mRNA delivery. Nature Reviews Materials. https:\/\/doi.org\/10.1038\/natrevmats.2017.56","journal-title":"Nature Reviews Materials"},{"issue":"13","key":"5598_CR20","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1182\/blood-2006-04-015024","volume":"108","author":"S Holtkamp","year":"2006","unstructured":"Holtkamp, S., Kreiter, S., Selmi, A., Simon, P., Koslowski, M., Huber, C., T\u00fcReci, O., & Sahin, U. (2006). Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. Blood, 108(13), 4009\u20134017. https:\/\/doi.org\/10.1182\/blood-2006-04-015024","journal-title":"Blood"},{"issue":"10","key":"5598_CR21","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.4161\/hv.25181","volume":"9","author":"K Kallen","year":"2013","unstructured":"Kallen, K., Heidenreich, R., Schnee, M., Petsch, B., Schlake, T., Thess, A., Baumhof, P., Scheel, B., Koch, S. D., & Fotin-Mleczek, M. (2013). A novel, disruptive vaccination technology. Human Vaccines & Immunotherapeutics, 9(10), 2263\u20132276. https:\/\/doi.org\/10.4161\/hv.25181","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"24","key":"5598_CR23","doi-asserted-by":"publisher","first-page":"7426","DOI":"10.1073\/pnas.1424329112","volume":"112","author":"Q Ke","year":"2015","unstructured":"Ke, Q., Ferrara, E., Radicchi, F., & Flammini, A. (2015). Defining and identifying sleeping beauties in science. Proceedings of the National Academy of Sciences, 112(24), 7426\u20137431. https:\/\/doi.org\/10.1073\/pnas.1424329112","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"5598_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/asi.5090140103","volume":"14","author":"MM Kessler","year":"1963","unstructured":"Kessler, M. M. (1963). Bibliographic coupling between scientific papers. American Documentation, 14(1), 10\u201325. https:\/\/doi.org\/10.1002\/asi.5090140103","journal-title":"American Documentation"},{"key":"5598_CR25","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1056\/NEJMoa030781","volume":"348","author":"TG Ksiazek","year":"2003","unstructured":"Ksiazek, T. G., Erdman, D., Goldsmith, C. S., Zaki, S. R., Peret, T., Emery, S., ong, S., Urbani, C., Comer, J. A., Lim, W., & Rollin, P. E. (2003). A novel coronavirus associated with severe acute respiratory syndrome. The New England Journal of Medicine, 348, 1953\u20131966. https:\/\/doi.org\/10.1056\/NEJMoa030781","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"5598_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1586\/14760584.2015.965690","volume":"14","author":"K Ljungberg","year":"2014","unstructured":"Ljungberg, K., & Liljestr\u00f6m, P. (2014). Self-replicating alphavirus RNA vaccines. Expert Review of Vaccines, 14(2), 177\u2013194. https:\/\/doi.org\/10.1586\/14760584.2015.965690","journal-title":"Expert Review of Vaccines"},{"issue":"8","key":"5598_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161193","volume":"11","author":"D Magini","year":"2016","unstructured":"Magini, D., Giovani, C., Mangiavacchi, S., Maccari, S., Cecchi, R., Ulmer, J. B., De Gregorio, E., Geall, A. J., Brazzoli, M., & Bertholet, S. (2016). Self-amplifying mRNA vaccines expressing multiple conserved influenza antigens confer protection against homologous and heterosubtypic viral challenge. PLoS ONE, 11(8), Article e0161193. https:\/\/doi.org\/10.1371\/journal.pone.0161193","journal-title":"PLoS ONE"},{"issue":"4","key":"5598_CR28","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1108\/eb026352","volume":"20","author":"J Martyn","year":"1964","unstructured":"Martyn, J. (1964). Bibliographic coupling. Journal of Documentation, 20(4), 236\u2013236. https:\/\/doi.org\/10.1108\/eb026352","journal-title":"Journal of Documentation"},{"key":"5598_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02698","author":"L Michel-Tod\u00f3","year":"2019","unstructured":"Michel-Tod\u00f3, L., Reche, P. A., Bigey, P., Pinazo, M., Gasc\u00f3n, J., & Alonso-Padilla, J. (2019). In silico design of an epitope-based vaccine ensemble for Chagas disease. Frontiers in Immunology. https:\/\/doi.org\/10.3389\/fimmu.2019.02698","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"5598_CR30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1586\/14760584.2015.986104","volume":"14","author":"P Midoux","year":"2014","unstructured":"Midoux, P., & Pichon, C. (2014). Lipid-based mRNA vaccine delivery systems. Expert Review of Vaccines, 14(2), 221\u2013234. https:\/\/doi.org\/10.1586\/14760584.2015.986104","journal-title":"Expert Review of Vaccines"},{"issue":"1","key":"5598_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11192-015-1765-5","volume":"106","author":"P Mongeon","year":"2016","unstructured":"Mongeon, P., & Paul-Hus, A. (2016). The journal coverage of Web of Science and Scopus: A comparative analysis. Scientometrics, 106(1), 213\u2013228. https:\/\/doi.org\/10.1007\/s11192-015-1765-5","journal-title":"Scientometrics"},{"key":"5598_CR32","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41586-020-2639-4","volume":"585","author":"MJ Mulligan","year":"2020","unstructured":"Mulligan, M. J., Lyke, K. E., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Neuzil, K., Raabe, V., Bailey, R., Swanson, K. A., & Li, P. (2020). Phase I\/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature, 585, 589\u2013593. https:\/\/doi.org\/10.1038\/s41586-020-2639-4","journal-title":"Nature"},{"key":"5598_CR33","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","volume":"217","author":"N Pardi","year":"2015","unstructured":"Pardi, N., Tuyishime, S., Muramatsu, H., Kariko, K., Mui, B. L., Tam, Y. K., Madden, T. D., Hope, M. J., & Weissman, D. (2015). Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes. Journal of Controlled Release, 217, 345\u2013351. https:\/\/doi.org\/10.1016\/j.jconrel.2015.08.007","journal-title":"Journal of Controlled Release"},{"issue":"27","key":"5598_CR34","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., P\u00e9rez Marc, G., Moreira, E. D., Zerbini, C., & Bailey, R. (2020). Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. New England Journal of Medicine, 383(27), 2603\u20132615. https:\/\/doi.org\/10.1056\/NEJMoa2034577","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"5598_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1136\/bmjspcare-2020-002675","volume":"11","author":"R Powell","year":"2021","unstructured":"Powell, R., Rodriquez-Campos, L., Opare-Lokko, E., Ebenso, B., & Allsop, M. (2021). Flattening\u2019one curve: What about \u2018raising the line\u2019on the other? COVID-19 and palliative care in low-income and middle-income countries. BMJ Supportive & Palliative Care, 11(2), 119\u2013121. https:\/\/doi.org\/10.1136\/bmjspcare-2020-002675","journal-title":"BMJ Supportive & Palliative Care"},{"issue":"15","key":"5598_CR36","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/sj.gt.3302964","volume":"14","author":"J Probst","year":"2007","unstructured":"Probst, J., Weide, B., Scheel, B., Pichler, B. J., Hoerr, I., Rammensee, H., & Pascolo, S. (2007). Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent. Gene Therapy, 14(15), 1175\u20131180. https:\/\/doi.org\/10.1038\/sj.gt.3302964","journal-title":"Gene Therapy"},{"issue":"5","key":"5598_CR37","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4155\/tde-2016-0006","volume":"7","author":"AM Reichmuth","year":"2016","unstructured":"Reichmuth, A. M., Oberli, M. A., Jaklenec, A., Langer, R., & Blankschtein, D. (2016). MRNA vaccine delivery using lipid nanoparticles. Therapeutic Delivery, 7(5), 319\u2013334. https:\/\/doi.org\/10.4155\/tde-2016-0006","journal-title":"Therapeutic Delivery"},{"issue":"10","key":"5598_CR38","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd4278","volume":"13","author":"U Sahin","year":"2014","unstructured":"Sahin, U., Karik\u00f3, K., & T\u00fcreci, \u00d6. (2014). mRNA-based therapeutics\u2014developing a new class of drugs. Nature Reviews. Drug Discovery, 13(10), 759\u2013780. https:\/\/doi.org\/10.1038\/nrd4278","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"11","key":"5598_CR39","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.4161\/rna.22269","volume":"9","author":"T Schlake","year":"2012","unstructured":"Schlake, T., Thess, A., Fotin-Mleczek, M., & Kallen, K. (2012). Developing mRNA-vaccine technologies. RNA Biology, 9(11), 1319\u20131330. https:\/\/doi.org\/10.4161\/rna.22269","journal-title":"RNA Biology"},{"issue":"6","key":"5598_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004746","volume":"10","author":"M Schnee","year":"2016","unstructured":"Schnee, M., Vogel, A. B., Voss, D., Petsch, B., Baumhof, P., Kramps, T., & Stitz, L. (2016). An mRNA vaccine encoding Rabies Virus Glycoprotein induces protection against lethal infection in mice and correlates of protection in adult and newborn pigs. PLoS Neglected Tropical Diseases, 10(6), Article e0004746. https:\/\/doi.org\/10.1371\/journal.pntd.0004746","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"2","key":"5598_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.mce.2003.10.078","volume":"213","author":"N Schutze","year":"2004","unstructured":"Schutze, N. (2004). siRNA technology. Molecular and Cellular Endocrinology, 213(2), 115\u2013119. https:\/\/doi.org\/10.1016\/j.mce.2003.10.078","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"4","key":"5598_CR42","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/asi.4630240406","volume":"24","author":"H Small","year":"1973","unstructured":"Small, H. (1973). Co-citation in the scientific literature: A new measure of the relationship between two documents. Journal of the American Society for Information Science, 24(4), 265\u2013269. https:\/\/doi.org\/10.1002\/asi.4630240406","journal-title":"Journal of the American Society for Information Science"},{"issue":"9","key":"5598_CR43","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/mt.2015.103","volume":"23","author":"A Thess","year":"2015","unstructured":"Thess, A., Grund, S., Mui, B. L., Hope, M. J., Baumhof, P., Fotin-Mleczek, M., & Schlake, T. (2015). Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals. Molecular Therapy, 23(9), 1456\u20131464. https:\/\/doi.org\/10.1038\/mt.2015.103","journal-title":"Molecular Therapy"},{"key":"5598_CR56","doi-asserted-by":"publisher","unstructured":"Turki, H., Hadj Taieb, M. A., & Ben Aouicha, M. (2022). Awakening sleeping beauties during the COVID-19 pandemic influences the citation impact of their references. Scientometrics, 127(10), 6047\u20136050. https:\/\/doi.org\/10.1007\/s11192-022-04501-8","DOI":"10.1007\/s11192-022-04501-8"},{"issue":"2","key":"5598_CR44","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","volume":"84","author":"NJ Van Eck","year":"2010","unstructured":"Van Eck, N. J., & Waltman, L. (2010). Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics, 84(2), 523\u2013538. https:\/\/doi.org\/10.1007\/s11192-009-0146-3","journal-title":"Scientometrics"},{"key":"5598_CR45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-3-319-10377-8_13","volume-title":"Measuring scholarly impact","author":"NJ Van Eck","year":"2014","unstructured":"Van Eck, N. J., & Waltman, L. (2014). Visualizing bibliometric networks. In Y. Ding, R. Rousseau, & D. Wolfram (Eds.), Measuring scholarly impact (pp. 285\u2013320). Springer."},{"issue":"3","key":"5598_CR46","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1023\/B:SCIE.0000018543.82441.f1","volume":"59","author":"AFJ Van Raan","year":"2004","unstructured":"Van Raan, A. F. J. (2004). Sleeping beauties in science. Scientometrics, 59(3), 467\u2013472. https:\/\/doi.org\/10.1023\/B:SCIE.0000018543.82441.f1","journal-title":"Scientometrics"},{"issue":"3","key":"5598_CR47","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s11192-016-2215-8","volume":"110","author":"AFJ Van Raan","year":"2017","unstructured":"Van Raan, A. F. J. (2017). Sleeping beauties cited in patents: Is there also a dormitory of inventions? Scientometrics, 110(3), 1123\u20131156. https:\/\/doi.org\/10.1007\/s11192-016-2215-8","journal-title":"Scientometrics"},{"key":"5598_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2019.100766","volume":"28","author":"R Verbeke","year":"2019","unstructured":"Verbeke, R., Lentacker, I., De Smedt, S. C., & Dewitte, H. (2019). Three decades of messenger RNA vaccine development. Nano Today, 28, Article 100766. https:\/\/doi.org\/10.1016\/j.nantod.2019.100766","journal-title":"Nano Today"},{"issue":"2","key":"5598_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12020102","volume":"12","author":"A Wadhwa","year":"2020","unstructured":"Wadhwa, A., Aljabbari, A., Lokras, A., Foged, C., & Thakur, A. (2020). Opportunities and challenges in the delivery of mRNA-based vaccines. Pharmaceutics, 12(2), Article 102. https:\/\/doi.org\/10.3390\/pharmaceutics12020102","journal-title":"Pharmaceutics"},{"key":"5598_CR50","doi-asserted-by":"publisher","unstructured":"Wang, F., Kream, R. M., & Stefano, G. B. (2020). An evidence based perspective on mRNA-SARS-COV-2 vaccine development. Medical Science Monitor. https:\/\/doi.org\/10.12659\/msm.924700","DOI":"10.12659\/msm.924700"},{"key":"5598_CR51","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.addr.2020.06.026","volume":"159","author":"D Witzigmann","year":"2020","unstructured":"Witzigmann, D., Kulkarni, J. A., Leung, J., Chen, S., Cullis, P. R., & Van Der Meel, R. (2020). Lipid nanoparticle technology for therapeutic gene regulation in the liver. Advanced Drug Delivery Reviews, 159, 344\u2013363. https:\/\/doi.org\/10.1016\/j.addr.2020.06.026","journal-title":"Advanced Drug Delivery Reviews"},{"key":"5598_CR52","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","volume":"367","author":"AM Zaki","year":"2012","unstructured":"Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D., & Fouchier, R. A. (2012). Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. New England Journal of Medicine, 367, 1814\u20131820. https:\/\/doi.org\/10.1056\/NEJMoa1211721","journal-title":"New England Journal of Medicine"}],"container-title":["Scientometrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11192-026-05598-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11192-026-05598-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11192-026-05598-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T12:13:58Z","timestamp":1779797638000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11192-026-05598-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["5598"],"URL":"https:\/\/doi.org\/10.1007\/s11192-026-05598-x","relation":{},"ISSN":["0138-9130","1588-2861"],"issn-type":[{"value":"0138-9130","type":"print"},{"value":"1588-2861","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}